Reviews
Recent insights in the potential role of imaging modalities for diagnosing patients with primary Sjögren’s syndrome
E. Mossel1, S. Arends2, H. Bootsma3
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, the Netherlands.
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, the Netherlands.
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, The Netherlands. h.bootsma@umcg.nl
CER13792
2020 Vol.38, N°4 ,Suppl.126
PI 0310, PF 0314
Reviews
Free to view
(click on article PDF icon to read the article)
PMID: 33025898 [PubMed]
Received: 09/07/2020
Accepted : 31/08/2020
In Press: 22/09/2020
Published: 23/10/2020
Abstract
Within the last year, interesting developments regarding the assessment of salivary gland involvement in patients with clinical suspicion of, or diagnosed with primary Sjögren’s syndrome (pSS) have been performed. In this review various topics will be discussed, starting with the use of salivary gland ultrasonography (SGUS) for the detection of glandular swelling. Furthermore, other imaging modalities, besides B-mode SGUS, which differentiate between pSS patients and healthy controls will be highlighted. Moreover, storage of ultrasonographic images and videos will be discussed briefly, as will be some potential biases and pitfalls. Finally, efforts that have been made to make incorporation of SGUS into the most recent classification criteria possible will be discussed, as well as the important steps that have been taken to develop a new semi-quantitative scoring system for the assessment of salivary gland involvement in patients with suspected or confirmed pSS.
